Compare AbCellera Biologics Inc (ABCL) vs OneSpan Inc (OSPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs OneSpan Inc — how do they compare? AbCellera Biologics Inc trades at $9.06 (market cap $2.99B), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: AbCellera Biologics Inc is far larger — about 5× OneSpan Inc's market cap, and OneSpan Inc pays a 3.19% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | OSPN | |
|---|---|---|
Market Cap | $2.99B | $600.69M |
Sector | Health | Technology |
52-Week High | $9.76 | $16.78 |
52-Week Low | $2.78 | $10.15 |
Enterprise Value | $2.58B | $569.77M |
Dividend Yield | — | 3.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
